Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 311

    1.

    Aliskiren Monotherapy Does Not Cause Paradoxical Blood Pressure Rises. Meta-Analysis of Data From 8 Clinical Trials.

    Stanton AV, Gradman AH, Schmieder RE, Nussberger J, Sarangapani R, Prescott MF.

    Hypertension. 2009 Nov 16. [Epub ahead of print]PMID: 19917876 [PubMed - as supplied by publisher]Related articles

    2.

    Hypertension and Diabetes: what are the pros to treating early surrogates?

    Schmieder RE.

    Diabetes Care. 2009 Nov;32 Suppl 2:S294-7. No abstract available. PMID: 19875568 [PubMed - in process]Related articles

    3.

    Improvement of hypertension management by structured physician education and feedback system: cluster randomized trial.

    Lüders S, Schrader J, Schmieder RE, Smolka W, Wegscheider K, Bestehorn K.

    Eur J Cardiovasc Prev Rehabil. 2009 Nov 6. [Epub ahead of print]PMID: 19901841 [PubMed - as supplied by publisher]Related articles

    4.

    Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.

    Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, van Zwieten PA, Viigimaa M, Zanchetti A.

    J Hypertens. 2009 Oct 15. [Epub ahead of print] No abstract available. PMID: 19838131 [PubMed - as supplied by publisher]Related articles

    5.

    Rosuvastatin does not affect intrarenal hemodynamics in patients with hypercholesterolemia.

    Ott C, Ritt M, Titze SI, Schäufele T, Schmieder RE.

    J Nephrol. 2009 Sep-Oct;22(5):675-81.PMID: 19810001 [PubMed - in process]Related articles

    6.

    Angiotensin blockade to reduce microvascular damage in diabetes mellitus.

    Schmieder RE, Martin S, Lang GE, Bramlage P, Böhm M.

    Dtsch Arztebl Int. 2009 Aug;106(34-35):556-62. Epub 2009 Aug 24.PMID: 19795011 [PubMed - in process]Related articlesFree article

    7.

    Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease.

    Verdecchia P, Sleight P, Mancia G, Fagard R, Trimarco B, Schmieder RE, Kim JH, Jennings G, Jansky P, Chen JH, Liu L, Gao P, Probstfield J, Teo K, Yusuf S; ONTARGET/TRANSCEND Investigators.

    Circulation. 2009 Oct 6;120(14):1380-9. Epub 2009 Sep 21.PMID: 19770395 [PubMed - indexed for MEDLINE]Related articles

    8.

    Wall-to-lumen ratio of retinal arterioles is related with urinary albumin excretion and altered vascular reactivity to infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine.

    Ritt M, Harazny JM, Ott C, Schneider MP, Schlaich MP, Michelson G, Schmieder RE.

    J Hypertens. 2009 Jul 21. [Epub ahead of print]PMID: 19625969 [PubMed - as supplied by publisher]Related articles

    9.

    [Hypertension and diastolic dysfunction]

    Schwab J, Schneider MP, Pauschinger M, Schmieder RE.

    MMW Fortschr Med. 2009 Jun 4;151(23):41-3. German. No abstract available. PMID: 19591353 [PubMed - indexed for MEDLINE]Related articles

    10.

    Gender is related to alterations of renal endothelial function in type 2 diabetes.

    Schneider MP, Ritt M, Raff U, Ott C, Schmieder RE.

    Nephrol Dial Transplant. 2009 Nov;24(11):3354-9. Epub 2009 Jun 30.PMID: 19567476 [PubMed - in process]Related articles

    11.

    Is a shared decision-making approach effective in improving hypertension management?

    Deinzer A, Veelken R, Kohnen R, Schmieder RE.

    J Clin Hypertens (Greenwich). 2009 May;11(5):266-70.PMID: 19534034 [PubMed - indexed for MEDLINE]Related articles

    12.

    Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension.

    Zanchetti A, Mancia G, Black HR, Oparil S, Waeber B, Schmieder RE, Bakris GL, Messerli FH, Kjeldsen SE, Ruilope LM.

    J Hypertens. 2009 Apr;27(4):673-9. Review.PMID: 19516168 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Antihypertensive therapy]

    Schmieder RE, Veelken R.

    MMW Fortschr Med. 2009 Apr 2;151(14):95-8; quiz 99. German. No abstract available. PMID: 19504848 [PubMed - indexed for MEDLINE]Related articles

    14.

    Risk prediction in subjects with high-normal blood pressure.

    Schneider MP, Schmieder RE.

    J Hypertens. 2009 Jun;27(6):1126-8. Review. No abstract available. PMID: 19454903 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of telmisartan on renal outcomes: a randomized trial.

    Mann JF, Schmieder RE, Dyal L, McQueen MJ, Schumacher H, Pogue J, Wang X, Probstfield JL, Avezum A, Cardona-Munoz E, Dagenais GR, Diaz R, Fodor G, Maillon JM, Rydén L, Yu CM, Teo KK, Yusuf S; TRANSCEND (Telmisartan Randomised Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease) Investigators.

    Ann Intern Med. 2009 Jul 7;151(1):1-10, W1-2. Epub 2009 May 18.PMID: 19451556 [PubMed - indexed for MEDLINE]Related articles

    16.

    Wall-to-lumen ratio of retinal arterioles as a tool to assess vascular changes.

    Ritt M, Schmieder RE.

    Hypertension. 2009 Aug;54(2):384-7. Epub 2009 May 18. Review. No abstract available. PMID: 19451413 [PubMed - indexed for MEDLINE]Related articles

    17.

    Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial.

    Schmieder RE, Philipp T, Guerediaga J, Gorostidi M, Bush C, Keefe DL.

    J Hypertens. 2009 Jul;27(7):1493-501.PMID: 19444142 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Optimal therapy of diabetic nephropathy: AVOID Study (Aliskiren in the evaluation of proteinuria in diabetes)]

    Schmieder RE, Nitschmann S.

    Internist (Berl). 2009 Jul;50(7):895-6. German. No abstract available. PMID: 19424672 [PubMed]Related articles

    19.

    The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics.

    Cowan BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, Jennings GL.

    Clin Res Cardiol. 2009 Jul;98(7):421-33. Epub 2009 Apr 4.PMID: 19347385 [PubMed - indexed for MEDLINE]Related articles

    20.

    Wall-to-lumen ratio of retinal arterioles and arteriole-to-venule ratio of retinal vessels in patients with cerebrovascular damage.

    Baleanu D, Ritt M, Harazny J, Heckmann J, Schmieder RE, Michelson G.

    Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4351-9. Epub 2009 Apr 1.PMID: 19339746 [PubMed - indexed for MEDLINE]Related articles

    21.

    Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

    Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F; AURORA Study Group.

    N Engl J Med. 2009 Apr 2;360(14):1395-407. Epub 2009 Mar 30.PMID: 19332456 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Fixed-dose manidipine/delapril versus losartan/hydrochlorothiazide in hypertensive patients with type 2 diabetes and microalbuminuria.

    Kohlmann O Jr, Roca-Cusachs A, Laurent S, Schmieder RE, Wenzel RR, Fogari R.

    Adv Ther. 2009 Mar;26(3):313-24. Epub 2009 Mar 28.PMID: 19330493 [PubMed - in process]Related articles

    23.

    The role of statins in the treatment of the metabolic syndrome.

    Ott C, Schmieder RE.

    Curr Hypertens Rep. 2009 Apr;11(2):143-9. Review.PMID: 19278604 [PubMed - indexed for MEDLINE]Related articles

    24.

    Statin treatment reduces glomerular inflammation and podocyte damage in rat deoxycorticosterone-acetate-salt hypertension.

    Hartner A, Klanke B, Cordasic N, Amann K, Schmieder RE, Veelken R, Hilgers KF.

    J Hypertens. 2009 Feb;27(2):376-85.PMID: 19226708 [PubMed - indexed for MEDLINE]Related articles

    25.

    Cardiovascular disease in patients with renal disease: the role of statins.

    Fellström B, Holdaas H, Jardine AG, Svensson MK, Gottlow M, Schmieder RE, Zannad F; AURORA Study Group.

    Curr Med Res Opin. 2009 Jan;25(1):271-85. Review.PMID: 19210158 [PubMed - indexed for MEDLINE]Related articles

    26.

    Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide.

    Schmieder RE, Philipp T, Guerediaga J, Gorostidi M, Smith B, Weissbach N, Maboudian M, Botha J, van Ingen H.

    Circulation. 2009 Jan 27;119(3):417-25. Epub 2009 Jan 12.PMID: 19139391 [PubMed - indexed for MEDLINE]Related articles

    27.

    Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus.

    Ritt M, Ott C, Raff U, Schneider MP, Schuster I, Hilgers KF, Schlaich MP, Schmieder RE.

    Am J Kidney Dis. 2009 Feb;53(2):281-9. Epub 2008 Dec 19.PMID: 19100670 [PubMed - indexed for MEDLINE]Related articles

    28.

    Elevated VEGF-plasma levels in young patients with mild essential hypertension.

    Stumpf C, Jukic J, Yilmaz A, Raaz D, Schmieder RE, Daniel WG, Garlichs CD.

    Eur J Clin Invest. 2009 Jan;39(1):31-6. Epub 2008 Dec 1.PMID: 19067736 [PubMed - indexed for MEDLINE]Related articles

    29.

    Effects of telmisartan and ramipril on adiponectin and blood pressure in patients with type 2 diabetes.

    Delles C, Raff U, Mimran A, Fauvel JP, Ruilope LM, Schmieder RE.

    Am J Hypertens. 2008 Dec;21(12):1330-6. Epub 2008 Nov 6.PMID: 18989258 [PubMed - indexed for MEDLINE]Related articles

    30.

    A novel-1364A/C aquaporin 5 gene promoter polymorphism influences the responses to salt loading of the renin-angiotensin-aldosterone system and of blood pressure in young healthy men.

    Adamzik M, Frey UH, Bitzer K, Jakob H, Baba HA, Schmieder RE, Schneider MP, Heusch G, Peters J, Siffert W.

    Basic Res Cardiol. 2008 Nov;103(6):598-610. Epub 2008 Oct 10.PMID: 18846354 [PubMed - indexed for MEDLINE]Related articles

    31.

    Blood pressure control in patients with comorbidities.

    Schmieder RE, Ruilope LM.

    J Clin Hypertens (Greenwich). 2008 Aug;10(8):624-31. Review.PMID: 18772645 [PubMed - indexed for MEDLINE]Related articles

    32.

    Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

    Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Metsärinne K, Oto A, Parkhomenko A, Piegas LS, Svendsen TL, Teo KK, Yusuf S; ONTARGET investigators.

    Lancet. 2008 Aug 16;372(9638):547-53.PMID: 18707986 [PubMed - indexed for MEDLINE]Related articles

    33.

    Impact of the endothelial nitric oxide synthase gene G894T polymorphism on renal endothelial function in patients with type 2 diabetes.

    Ritt M, Ott C, Delles C, Schneider MP, Schmieder RE.

    Pharmacogenet Genomics. 2008 Aug;18(8):699-707.PMID: 18622262 [PubMed - indexed for MEDLINE]Related articles

    34.

    [Combination therapy: used too little and too late?]

    Veelken R, Schmieder RE.

    MMW Fortschr Med. 2008 Jun 12;150(24):27-8, 30. German. No abstract available. PMID: 18609771 [PubMed - indexed for MEDLINE]Related articles

    35.

    Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trial.

    Kjeldsen SE, McInnes GT, Mancia G, Hua TA, Julius S, Weber MA, Coca A, Girerd X, Jamerson K, Larochelle P, Macdonald T, Schmieder RE, Anthony Schork M, Viskoper R, Widimsky J, Zanchetti A.

    Blood Press. 2008;17(3):170-7.PMID: 18608200 [PubMed - indexed for MEDLINE]Related articles

    36.

    [Effects of long-term antihypertensive therapy with losartan on blood pressure and cognitive function in patients with essential hypertension and other cerebrovascular risk factors (AWARE observational study)]

    Schrader J, Lüders S, Diener HC, Haller H, Schmieder RE, Wahle K, Smolka W, Jung C, Bestehorn K.

    Med Klin (Munich). 2008 Jul 15;103(7):491-9. German. PMID: 18604484 [PubMed - indexed for MEDLINE]Related articles

    37.

    The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.

    Lüders S, Schrader J, Berger J, Unger T, Zidek W, Böhm M, Middeke M, Motz W, Lübcke C, Gansz A, Brokamp L, Schmieder RE, Trenkwalder P, Haller H, Dominiak P; PHARAO Study Group.

    J Hypertens. 2008 Jul;26(7):1487-96.PMID: 18551027 [PubMed - indexed for MEDLINE]Related articles

    38.

    Analysis of retinal arteriolar structure in never-treated patients with essential hypertension.

    Ritt M, Harazny JM, Ott C, Schlaich MP, Schneider MP, Michelson G, Schmieder RE.

    J Hypertens. 2008 Jul;26(7):1427-34.PMID: 18551020 [PubMed - indexed for MEDLINE]Related articles

    39.

    Glutathione S-transferase variants and hypertension.

    Delles C, Padmanabhan S, Lee WK, Miller WH, McBride MW, McClure JD, Brain NJ, Wallace C, Marçano AC, Schmieder RE, Brown MJ, Caulfield MJ, Munroe PB, Farrall M, Webster J, Connell JM, Dominiczak AF.

    J Hypertens. 2008 Jul;26(7):1343-52.PMID: 18551009 [PubMed - indexed for MEDLINE]Related articles

    40.

    Efficacy, safety and tolerability of valsartan 80 mg compared to irbesartan 150 mg in hypertensive patients on long-term hemodialysis (VALID study).

    Leidig M, Bambauer R, Kirchertz EJ, Szabã T, Handrock R, Leinung D, Baier M, Schmieder RE.

    Clin Nephrol. 2008 Jun;69(6):425-32.PMID: 18538118 [PubMed - indexed for MEDLINE]Related articles

    41.

    Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.

    Klanke B, Cordasic N, Hartner A, Schmieder RE, Veelken R, Hilgers KF.

    Nephrol Dial Transplant. 2008 Nov;23(11):3456-63. Epub 2008 May 30.PMID: 18515791 [PubMed - indexed for MEDLINE]Related articles

    42.

    Left ventricular hypertrophy and clinical outcomes in hypertensive patients.

    Ruilope LM, Schmieder RE.

    Am J Hypertens. 2008 May;21(5):500-8. Epub 2008 Mar 13. Review.PMID: 18437140 [PubMed - indexed for MEDLINE]Related articles

    43.

    Effect of angiotensin receptor blockade on central haemodynamics in essential hypertension: results of a randomised trial.

    Schneider MP, Delles C, Klingbeil AU, Ludwig M, Kolloch RE, Krekler M, Stumpe KO, Schmieder RE.

    J Renin Angiotensin Aldosterone Syst. 2008 Mar;9(1):49-56.PMID: 18404609 [PubMed - indexed for MEDLINE]Related articles

    44.

    Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.

    Roca-Cusachs A, Schmieder RE, Triposkiadis F, Wenzel RR, Laurent S, Kohlmann O Jr, Fogari R; MORE Study Group.

    J Hypertens. 2008 Apr;26(4):813-8.PMID: 18327093 [PubMed - indexed for MEDLINE]Related articles

    45.

    Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial).

    Aksnes TA, Schmieder RE, Kjeldsen SE, Ghani S, Hua TA, Julius S.

    Am J Cardiol. 2008 Mar 1;101(5):634-8. Epub 2008 Jan 15.PMID: 18308012 [PubMed - indexed for MEDLINE]Related articles

    46.

    Effects of angiotensin II type 1-receptor blockade on retinal endothelial function.

    Ott C, Schlaich MP, Harazny J, Schmidt BM, Michelson G, Schmieder RE.

    J Hypertens. 2008 Mar;26(3):516-22.PMID: 18300863 [PubMed - indexed for MEDLINE]Related articles

    47.

    Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial.

    Schmieder RE, Kjeldsen SE, Julius S, McInnes GT, Zanchetti A, Hua TA; VALUE Trial Group.

    J Hypertens. 2008 Mar;26(3):403-11.PMID: 18300848 [PubMed - indexed for MEDLINE]Related articles

    48.

    A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease.

    Zeltner R, Hilgers KF, Schmieder RE, Porst M, Schulze BD, Hartner A.

    Nephron Clin Pract. 2008;108(3):c169-75. Epub 2008 Feb 14.PMID: 18277079 [PubMed - indexed for MEDLINE]Related articles

    49.

    (Pro)renin receptor peptide inhibitor "handle-region" peptide does not affect hypertensive nephrosclerosis in Goldblatt rats.

    Muller DN, Klanke B, Feldt S, Cordasic N, Hartner A, Schmieder RE, Luft FC, Hilgers KF.

    Hypertension. 2008 Mar;51(3):676-81. Epub 2008 Jan 22.PMID: 18212268 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Renin inhibitors: optimal strategy for renal protection.

    Schmieder RE.

    Curr Hypertens Rep. 2007 Nov;9(5):415-21. Review.PMID: 18177590 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...